RenovoRx RNXT
NASDAQ RNXT
$1.23 +0.03 (+2.50%)
At close: Oct 21, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Operating Leases (2024 - 2026)

Updated

RenovoRx (RNXT) posted Operating Leases of $259,000 for Q2 2026, up 60.9% from $161,000 a year earlier and up 232.1% from the prior quarter.

Analysis

RenovoRx (RNXT) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, RenovoRx's Operating Leases came in at $107,000, down 49.5% from FY2024.

  • In prior years, RenovoRx's Operating Leases was $212,000 in FY2024.
  • According to Business Quant data, Operating Leases for the three prior quarters was $78,000 (Q1 2026), $107,000 (Q4 2025) and $134,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 RenovoRx 58.89 Mn 19.92 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 259,000.00
Mar 31, 2026 78,000.00
Dec 31, 2025 107,000.00
Sep 30, 2025 134,000.00
Jun 30, 2025 161,000.00
Mar 31, 2025 186,000.00
Dec 31, 2024 212,000.00
API Access

RenovoRx Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RNXT&period=max&api_key=YOUR_API_KEY